Israeli-founded AZTherapies is in Phase 3 trials for its ALZT-OP1 for Alzheimer’s disease. The treatment also suppresses the immune system’s “cytokine storm” that is often lethal to Covid-19 infected patients. AZTherapies is building commercial partnerships with Israeli institutions.
https://worldisraelnews.com/one-new-drug-may-treat-both-covid-19-and-alzheimers/